Td Asset Management Inc Hille Vax, Inc. Transaction History

Td Asset Management Inc

  • $107 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024
BUY
$11.86 - $15.93 $225,340 - $302,670
19,000 Added 53.92%
54,236 $784,000
Q1 2024

May 08, 2024
BUY
$14.15 - $19.75 $236,418 - $329,983
16,708 Added 90.18%
35,236 $585,000
Q2 2022

Aug 04, 2022
BUY
$8.7 - $20.18 $161,193 - $373,895
18,528 New
18,528 $203,000

Others Institutions Holding HLVX

# of Institutions
80
Shares Held
36.8M
Call Options Held
0
Put Options Held
0
View Full List

About HilleVax, Inc.

HLVX Quotes by TradingView
  • Ticker HLVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,427,200
  • Market Cap $66.9M
  • Description
  • HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
More about HLVX
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email